{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T02:11:12Z","timestamp":1755828672785,"version":"3.44.0"},"reference-count":34,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"5","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Background: This study aimed to evaluate the effects of dexmedetomidine (DEX) in patients undergoing valve replacement surgery for rheumatic heart disease (RHD), focusing on its impact on serum levels of inflammatory markers (IL-8, IL-10, TNF-a) and myocardial injury markers (Cardiac Troponin I [cTnI], Creatine Kinase-MB [CK-MB]). Methods: A total of 140 patients undergoing cardiopulmonary bypass (CPB) valve replacement surgery at West China Hospital, Sichuan University, between January 2022 and December 2024 were randomly assigned to two groups: the observation group (DEX) and the control group (normal saline). Key perioperative parameters were analysed, including anaesthetic dosage, myocardial injury markers, immune function (CD4+, CD8+, and CD4+\/CD8+ ratio), inflammatory factors, and adverse reactions. Results: The observation group required significantly lower anaesthetic dosages than the control group. Additionally, the observation group exhibited higher heart rate (HR) at T5 and higher mean arterial pressure (MAP) at T2, T3, and T5 (P&lt; 0.05). Myocardial injury markers (cTnI and CK-MB) were significantly lower in the observation group (P&lt; 0.05). While preoperative cellular immune function (CD4+, CD8+, and CD4+\/CD8+) was similar between both groups, postoperative measurements showed significantly higher CD4+ and CD4+\/CD8+ ratios, and lower CD8+ in the observation group (P &lt; 0.05). Regarding inflammatory markers, IL-8 and TNF-a levels were significantly lower, while IL-10 was higher in the observation group postoperatively (P &lt; 0 .0 5). There were no significant differences in adverse reactions between the two groups (P &gt; 0 .0 5). Conclusions: Dexmedetomidine (DEX) reduces anaesthetic usage, supports hemodynamic stability, mitigates myocardial injury, and lowers postoperative inflammatory responses in patients undergoing RHD valve replacement surgery.<\/jats:p>","DOI":"10.5937\/jomb0-56030","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:01:51Z","timestamp":1742533311000},"page":"1028-1037","source":"Crossref","is-referenced-by-count":0,"title":["The serum levels of IL-8, IL-10, and TNF-a, cardiac troponin I, creatine kinase-MB in patients with rheumatic heart disease received dexmedetomidine"],"prefix":"10.5937","volume":"44","author":[{"given":"Dongmei","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"doi-asserted-by":"crossref","unstructured":"Kumar RK, Antunes MJ, Beaton A, Mirabel M, Nkomo VT, Okello E, Regmi PR, Remenyi B, Sliwa-Hahnle K, Zuhlke LJ, Sable C. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association. Circulation 2020; 142(20): e337-e357;","key":"ref1","DOI":"10.1161\/CIR.0000000000000921"},{"doi-asserted-by":"crossref","unstructured":"Marijon E, Mocumbi A, Narayanan K, Jouven X, Celermajer DS. Persisting burden and challenges of rheumatic heart disease. Eur Heart J 2021; 42(34): 3338-48;","key":"ref2","DOI":"10.1093\/eurheartj\/ehab407"},{"doi-asserted-by":"crossref","unstructured":"Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, Canales L, Carapetis J, DeWyer A, Lwabi P, Mirabe M, Mocumbi AO, Murali M, Nakitto M, Ndagire E, Nunes MCP, Omara IO, Samacki R, Scheel A, Wilson N, Zimmerman M, Zuhlke L, Karthikeyan G, Sable CA, Steer AC. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med 2022; 386(3): 230-40;","key":"ref3","DOI":"10.1056\/NEJMoa2102074"},{"doi-asserted-by":"crossref","unstructured":"Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation. N Engl J Med 2022; 387(22): 2100-1;","key":"ref4","DOI":"10.1056\/NEJMc2213437"},{"doi-asserted-by":"crossref","unstructured":"Katzenellenbogen JM, Bond Smith D, Seth RJ, Dempsey K, Cannon J, Stacey I, Wade V, de Klerk N, Greenland M, Sanfilippo FM, Brown A, Carapetis JR, Wyber R, Nedkoff L, Hung J, Bessarab D, Ralph AP. Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change. J Am Heart Assoc 2020; 9(19): e016851(1-26);","key":"ref5","DOI":"10.1161\/JAHA.120.016851"},{"doi-asserted-by":"crossref","unstructured":"Muhamed B, Parks T, Sliwa K. Genetics of rheumatic fever and rheumatic heart disease. Nat Rev Cardiol 2020; 17(3): 145-54;","key":"ref6","DOI":"10.1038\/s41569-019-0258-2"},{"doi-asserted-by":"crossref","unstructured":"Gong HY, Wang ZY, Sui YZ, Zhao JJ, Jing YY, Wang M. Effects of dexmedetomidine combined with propofol on peri-anesthesia hemodynamics and postoperative sedation and analgesia in patients undergoing radical esophagectomy. J Biol Regul Homeost Agents 2020; 34(6): 2171-5;","key":"ref7","DOI":"10.23812\/20-415-A"},{"doi-asserted-by":"crossref","unstructured":"Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol 2019; 72(4): 323-30;","key":"ref8","DOI":"10.4097\/kja.19259"},{"doi-asserted-by":"crossref","unstructured":"Zhao Y, He JS, Yu N, Jia CX, Wang SL. Mechanisms of dexmedetomidine in neuropathic pain. Front Neurosci 2020; 14: 330(1-11);","key":"ref9","DOI":"10.3389\/fnins.2020.00330"},{"doi-asserted-by":"crossref","unstructured":"Chen W, Wang Y, Pan ZG, Chen XY, Luo DH, Wang HY. Protective effects of dexmedetomidine on the ischemic myocardium in patients undergoing rheumatic heart valve replacement surgery. Exp Ther Med 2021; 21(5): 1-9;","key":"ref10","DOI":"10.3892\/etm.2021.9844"},{"doi-asserted-by":"crossref","unstructured":"Abdelrahman KA, Hassan SA, Mohammed AA, Abdelhakeem EE, Abd-Elshafy SK, Salama RH, Abdalla EM. The effect of dexmedetomidine on the inflammatory response in children undergoing repair of congenital heart disease: a randomised controlled clinical trial. Egypt J Anaesth 2020; 36(1): 297-304;","key":"ref11","DOI":"10.1080\/11101849.2020.1849957"},{"doi-asserted-by":"crossref","unstructured":"Depuru A, Bhatia N, Bhagat H, Singh A. Awake Cranioplasty in a Patient with Rheumatic Heart Disease: A Novel Approach. J Neuroanaesthesiol Crit Care 2022; 9(03): 183-5;","key":"ref12","DOI":"10.1055\/s-0042-1756429"},{"unstructured":"Hendrix JM, Garmon EH. American Society of Anesthesiologists Physical Status Classification System. [Updated 2025 Feb 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441940;","key":"ref13"},{"doi-asserted-by":"crossref","unstructured":"Bredy C, Ministeri M, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, et al. New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome. Eur Heart J Qual Care Clin Outcomes 2018; 4(1): 51-8;","key":"ref14","DOI":"10.1093\/ehjqcco\/qcx031"},{"doi-asserted-by":"crossref","unstructured":"Cheng YT, Lee KT, Chang CH, Wu VCC, Chan YS, Chen DY, Chu PH, Chou AH, Liu KS, Chen SW. Effects of dexmedetomidine on surgery for type A acute aortic dissection outcome. Sci Rep 2022; 12(1): 2761(1-7);","key":"ref15","DOI":"10.1038\/s41598-022-06710-w"},{"doi-asserted-by":"crossref","unstructured":"Wu HH, Tang JQ, Pan JM, Han M, Cai HJ, Zhang H. Effects of dexmedetomidine on stress hormones in patients undergoing cardiac valve replacement: a randomised controlled trial. BMC Anesthesiol 2020; 20(1): 142(1-9);","key":"ref16","DOI":"10.1186\/s12871-020-00993-0"},{"doi-asserted-by":"crossref","unstructured":"Chang JH, Jin MM, Liu JT. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia\/reperfusion injury in diabetic rats by activating PI3K\/Akt signaling in vivo and in vitro. Biomed Pharmacother 2020; 127: 110188(1-10);","key":"ref17","DOI":"10.1016\/j.biopha.2020.110188"},{"doi-asserted-by":"crossref","unstructured":"Huang LL, Qin CQ, Wang L, Zhang TJ, Li JG. Effects of dexmedetomidine on immune response in patients undergoing radical and reconstructive surgery for oral cancer. Oncol Lett 2021; 21(2): 106(1-8);","key":"ref18","DOI":"10.3892\/ol.2020.12367"},{"unstructured":"Liu GC, Sun K, Fu HG, Dong TL, Yuan F. Effects of dexmedetomidine on injury of lungs and CHOP protein expression in elderly patients with lung cancer during one-lung ventilation. Zhonghua yi xue za zhi 2020; 100(1): 37-41;","key":"ref19"},{"doi-asserted-by":"crossref","unstructured":"Xin X, Chen J, Hua W, Wang HY. Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment. Int J Geriatr Psychiatr 2021; 36(1): 143-51;","key":"ref20","DOI":"10.1002\/gps.5406"},{"doi-asserted-by":"crossref","unstructured":"Carozza R, Fazzi D, Pietrini A, Cefarelli M, Mazzocca F, Vessella W, Berretta P, Romagnoli M, Alfonsi J, Zahedi HM, Munch C, Di Eusanio M. Minimally invasive aortic valve replacement: extracorporeal circulation optimisation and minimally invasive extracorporeal circulation system evolution. Perfusion-UK 2020; 35(8): 865-9;","key":"ref21","DOI":"10.1177\/0267659120913385"},{"doi-asserted-by":"crossref","unstructured":"Lovell S, Simon B, Boudreau EC, Mankin J, Jeffery N. Randomised clinical trial comparing outcomes after fentanyl or ketamine dexmedetomidine analgesia in thoracolumbar spinal surgery in dogs. J Vet Intern Med 2022; 36(5): 1742-51;","key":"ref22","DOI":"10.1111\/jvim.16514"},{"doi-asserted-by":"crossref","unstructured":"Zhai WQ, Yang LM, Sun P, Li YF, Han JG, Wang GL. Effect of dexmedetomidine on hemodynamic changes and inflammatory responses in patients undergoing off-pump coronary-artery bypass grafting. Exp Ther Med 2020; 20(6): 250(1-7);","key":"ref23","DOI":"10.3892\/etm.2020.9380"},{"unstructured":"Cui C, Yu DN, Wang H, Kang Y, Long RC, Zhu Y, Ma J. Sedative effect of dexmedetomidine in induced abortion. Int J Clin Exp Med 2019; 12(10): 12363-9;","key":"ref24"},{"doi-asserted-by":"crossref","unstructured":"Tan C, Yan ST, Shen J, Wu H, Yu LY, Wang Y, Tian SP, Zhou W, Wu Y, Zhang ZA. Effects of dexmedetomidine on cardiac electrophysiology in patients undergoing general anesthesia during perioperative period: a randomised controlled trial. BMC Anesthesiol 2022; 22(1): 271(1-14);","key":"ref25","DOI":"10.1186\/s12871-022-01811-5"},{"doi-asserted-by":"crossref","unstructured":"Wang K, Wu MG, Xu J, Wu CS, Zhang BH, Wang GN, Ma DQ. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth 2019; 123(6): 777-94;","key":"ref26","DOI":"10.1016\/j.bja.2019.07.027"},{"doi-asserted-by":"crossref","unstructured":"Wen QP, Miao Z, Wu P, Wang J, Zhou FC, Lin Y, Lu XY, Lv R, Hou QH. Whole-course application of dexmedetomidine combined with ketorolac in nonnarcotic postoperative analgesia for patients with lung cancer undergoing thoracoscopic surgery: a randomised control trial. Pain Physician 2020; 23(2): E185-E193;","key":"ref27","DOI":"10.36076\/ppj.2020\/23\/E185"},{"doi-asserted-by":"crossref","unstructured":"Chen R, Sun Y, Lv J, Dou XL, Dai MS, Sun SJ, Lin Y. Effects of dexmedetomidine on immune cells: a narrative review. Front Pharmacol 2022; 13: 829951(1-12);","key":"ref28","DOI":"10.3389\/fphar.2022.829951"},{"doi-asserted-by":"crossref","unstructured":"Ding MY, Chen Y, Luan HF, Zhang XB, Zhao ZB, Wu Y. Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes. Exp Ther Med 2019; 18(3): 2323-31;","key":"ref29","DOI":"10.3892\/etm.2019.7790"},{"doi-asserted-by":"crossref","unstructured":"Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand M, Li R, Cy Bal SM, Heesters BA, Vila-Nadal G, Hunewald O, Montamat G, He FQ, Ollert M, Fedina O, Lao-Araya M, Vijverberg SJH, Maitland-van der Zee AH, van Drunen CM, Fokkens WJ, Durham SR, Spits H, Shamji MH. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity 2021; 54(2): 291-307;","key":"ref30","DOI":"10.1016\/j.immuni.2020.12.013"},{"doi-asserted-by":"crossref","unstructured":"Fang DF, Zhu JF. Molecular switches for regulating the differentiation of inflammatory and IL-10-producing anti-inflammatory T-helper cells. Cell Mol Life Sci 2020; 77(2): 289-303;","key":"ref31","DOI":"10.1007\/s00018-019-03277-0"},{"doi-asserted-by":"crossref","unstructured":"Dong WT, Li X, Wang XK, Cheng X, Kong LD, Guo ZY, Jing H. Influence of Dexmedetomidine on Cognitive Function and Inflammatory Factors in Rats and Analysis of Its Molecular Mechanism after Cardiac Surgery under Cardiopulmonary Bypass. Cell Mol Biol 2022; 68(2): 119-25;","key":"ref32","DOI":"10.14715\/cmb\/2022.68.2.17"},{"unstructured":"Shan Y, Xie K, Zhou Q, He R, Chen Z, Feng W. Sevoflurane alleviates myocardial ischemia\/reperfusion injury via activation of heat shock protein-70 in patients undergoing double valve replacement surgery. Am J Transl Res 2022; 14(8): 5529-40;","key":"ref33"},{"doi-asserted-by":"crossref","unstructured":"Netala VR, Teertam SK, Li H, Zhang Z. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies. Cells 2024; 13(17);","key":"ref34","DOI":"10.3390\/cells13171471"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Nivoi IL-8, IL-10 i TNF-a u serumu, kardijalnog troponina i, i kreatin kinaze-mb kod pacijenata sa reumatskom bole\u0161\u0107u srca koji su primili deksmedetomidin"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582505028Y.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T13:54:12Z","timestamp":1755784452000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582505028Y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-56030","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"type":"print","value":"1452-8258"},{"type":"electronic","value":"1452-8266"}],"subject":[],"published":{"date-parts":[[2025]]}}}